Those in the LRRK2 and PRKN compound heterozygous/homozygous groups were more likely to have a first-degree relative with Parkinson’s disease (40%, 47% versus 19%; P = 1.11 × 10−11 and 1.36 × 10−6). Here, PRKN is linked to Parkinson disease.